Viropharma Inc $49.72
|Trade Time:||Dec 04 04:00 PM Eastern Daylight Time|
|Change:||0.22 (0.44 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get VPHM Trend Analysis - it has outperformed the S&P 500 by 73%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|2/20/2013||BROOKE PAUL A||Director||10,000||$1.77||9.57%|
|2/06/2013||BROOKE PAUL A||Director||10,000||$1.77||9.57%|
|12/27/2012||Broom Colin MD||VP & Chief Scientific Officer||10,000||$1.84||49.59%|
|12/24/2012||Broom Colin MD||VP & Chief Scientific Officer||-17,500||$22.53||-31.72%|
|12/24/2012||Broom Colin MD||VP & Chief Scientific Officer||17,500||$1.84||46.46%|
VPHM Stock Analysis
- No results found.
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!